Portfolio company
CamGene Therapeutics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This biotechnology company develops RNA-based medicines and lipid nanoparticle delivery technologies to treat hearing loss for patients with cellular dysfunction or cochlear implants.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CamGene
This company develops RNA-based therapeutics using lipid nanoparticle technology to treat hearing loss for patients with cellular dysfunction or undergoing cochlear implant surgery.
Decibel Therapeutics
This biotechnology company develops gene therapies to restore hearing and balance for patients with congenital hearing loss and related genetic disorders.
Sensorion
This company develops gene therapies and small molecule drugs to restore, treat and prevent inner ear disorders for patients with hearing loss.
Akouos
The company develops gene therapies to restore, improve and preserve hearing for individuals with disabling sensorineural hearing loss.
CureAge
This company develops curative gene therapies for patients with neurofibromatosis type 1 and other peripheral nerve diseases using lipid nanoparticle technology.
Averna Therapeutics
This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.
ReCode Therapeutics
This company develops mRNA and gene correction therapies delivered via lipid nanoparticles for patients with cystic fibrosis and primary ciliary dyskinesia.
Shape Therapeutics
The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.
